Category: Federal Forum Posters
Purpose: There has been a rapid increase in the female Veteran population over the last 40 years. Women of childbearing age comprise a large percentage of female Veterans and may require contraceptive counseling in the event a potentially teratogenic medication (Pregnancy Category D or X) is prescribed. According to multiple studies, overall documentation of contraceptive counseling is lacking. Our purpose is to perform a quality improvement project to evaluate reproductive-aged women enrolled in Women’s Health or Prime Care clinics at Michael E. DeBakey VA Medical Center (MEDVAMC) and describe the rate of documented contraceptive counseling for those prescribed potentially teratogenic medications.
Methods: The primary objective of this initiative is to determine the rate at which contraceptive counseling is provided to women of childbearing age prescribed teratogenic medications at a VA medical center. Secondary objectives include the rates of contraception use and pregnancy testing. This project will be a retrospective chart review from January 2017 to August 2018. Patients included are female Veterans between 18-45 years of age who made 2 or more visits to MEDVAMC prior to filling a prescription for a statin, angiotensin-converting enzyme inhibitor (ACEI), or angiotensin II receptor blocker (ARB). Women with a documented history of hysterectomy, menopause or tubal ligation and women prescribed potentially teratogenic medications with special requirements (i.e. REMS) will be excluded. A woman will be considered to have received contraceptive counseling if there is evidence in the electronic medical chart that she received contraceptive counseling, contraceptive pharmacotherapy or family planning counseling in the 2 years prior to the date on which the original prescription was dispensed. Pregnancy testing will be identified in the electronic medical chart by positive or negative results for human chorionic gonadotropin (hCG). Statistical analysis will include descriptive statistics. This project has been approved by MEDVAMC Quality Assurance and Regulatory Affairs.
Results: not applicable
Conclusion: not applicable
Chandler Schexnayder– PGY1 Pharmacy Practice Resident, Michael E. DeBakey Veteran Affairs Medical Center, Houston, TX